CASC8 and urinary bladder carcinoma: Hu R. G. et al. (2017) found that the lncRNA cancer susceptibility candidate 8 (CASC8) was significantly down-regulated in bladder cancers and associated with the advanced stage of bladder cancer patients, overexpression of which remarkably suppressed the bladder cancer cell proliferation.